Light-Triggered Retention and Cascaded Therapy of Albumin-Based Theranostic Nanomedicines to Alleviate Tumor Adaptive Treatment Tolerance-Reference-Cited by-同舟云学术

Light-Triggered Retention and Cascaded Therapy of Albumin-Based Theranostic Nanomedicines to Alleviate Tumor Adaptive Treatment Tolerance

Published:2018-03-07 Issue:17 Volume:28 Page:1707291
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Chen Jing¹,Liu Lu²,Motevalli Seyed Mohammad²,Wu Xiaoli¹,Yang Xiao-Hong³,Li Xianlei²,Han Lu³,Magrini Andrea⁴,Guo Weisheng²,Chang Jin¹,Bottini Massimo²⁵,Liang Xing-Jie²^ORCID

Affiliation:

1. School of Life Sciences; Tianjin University; Tianjin Engineering Center of Micro Nano Biomaterials and Detection Treatment Technology; Collaborative Innovation Center of Chemical Science and Engineering; Tianjin 300072 P. R. China

2. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety; CAS Center for Excellence in Nanoscience; National Center for Nanoscience and Technology of China; Beijing 100190 P. R. China

3. Beijing Engineering Research Center of Printed Electronics; Beijing Institute of Graphic Communication; Beijing 102600 P. R. China

4. Department of Biopathology and Imaging Diagnostics; University of Rome Tor Vergata; Rome 00133 Italy

5. Department of Experimental Medicine and Surgery; University of Rome Tor Vergata; Rome 00133 Italy

Funder

National Natural Science Foundation of China

National Distinguished Young Scholars

Strategic Priority Research Program

Chinese Academy of Sciences

cross training program for high level talents of Beijing Universities

Publisher

Wiley

Subject